The human papilloma virus (HPV) vaccine could be used to reduce the risk of cervical lesions, new research has discovered.
HPV jabs have been incorporated into standard childhood vaccines in Denmark since 2006.
Doctors from the Unit of Virus, Lifestyle and Genes and the Danish Cancer and Society Research Center in Copenhagen analysed data collected from women born between 1989 and 1999.
The number of cases of cervical lesions was compared between those who had received the HPV vaccine as a child and those who had not.
It was found that vaccinated females had a significantly reduced risk of developing cervical lesions, while among girls born in the late 1990s who received the injection as youngsters, no cases were reported.
Susanne Kruger Kjaer, lead author of the study, said: "In conclusion, our results show that vaccination with the quadrivalent HPV vaccine is already effective in reducing the risk of cervical precursor lesions."